Milrixa
Basic Information
Category
Subcategory & Sub-subcategory
Trade Type
Sell
Product Name
Milrixa
Substance
Manufacturer(s)
Registered Market
Specifications
- Dosage Form: Solution intramuscular injection or intravenous injection
- Packaging: Box comprising 1 ampoule x 4 mL
- Strength: 600mg/4ml
- Standards: In-house standard
- Shelf Life: 24 month
Documents
Drug Marketing Authorization Number
Document No.: 520110039726
Issue Date: May 28, 2026
Expiry Date: May 28, 2031
Note: 402/QĐ-QLD | 129.1
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Matched Products & Services
B2B matches based on trade type, category, specifications & price range
Similar Products & Services
Products & Services related to what you're viewing
People Also Viewed
Other products & services viewed by people who looked at this product
Leave your rating & comment